Status:
NOT_YET_RECRUITING
Better Options for Lymphatic Filariasis Treatment
Lead Sponsor:
Medicines Development for Global Health
Collaborating Sponsors:
Murdoch Childrens Research Institute
Kirby Institute
Conditions:
Lymphatic Filariasis
Scabies
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
The goal of this clinical trial is to learn if mass drug administration with moxidectin in combination with diethylcarbamazine, and albendazole (MoxDA) can treat lymphatic filariasis, scabies and stro...
Eligibility Criteria
Inclusion
- Provision of signed and dated informed consent.
- Resident in one of the study locations.
Exclusion
- There are no exclusion criteria to participation in the study.
- Treatment
Key Trial Info
Start Date :
March 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2028
Estimated Enrollment :
5100 Patients enrolled
Trial Details
Trial ID
NCT07159373
Start Date
March 1 2026
End Date
June 1 2028
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ministry of Health and Medical Services Fiji
Suva, Fiji